Physical Function in Patients With Chronic Obstructive Pulmonary Disease

COPD Clinical Trial

Official title:

Physical Function in Patients With Chronic Obstructive Pulmonary Disease

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT04107831
• Other study ID #: HaukelandUH- 2019/852
• Status: Active, not recruiting
• Phase: N/A
• Start date: August 9, 2019
• Est. completion date: December 31, 2024

Study information

• Verified date: March 2023
• Source: Haukeland University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aims of the study are to examine the responsiveness of, and the correlation between field walk tests and physical performance test in patients with chronic obstructive pulmonary disease (COPD) after participating in pulmonary rehabilitation.

Description:

Patients with COPD who are participating at pulmonary rehabilitation (PR) at Haukeland University Hospital will be asked and consecutive enrolled to the study. Before and after PR the six-minute walk test, incremental- and endurance shuttle walk test, 30 sec sit-to-stand test and stair test will be used to evaluate change in physical capacity and -performance.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 50
• Est. completion date: December 31, 2024
• Est. primary completion date: December 31, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Diagnosed with COPD, Forced expiratory volume in 1 sec (FEV1)/Forced vital capacity (FVC) <0.7 and FEV1<80% of predicted value.

• Able to walk corridor and stairs

• Norwegian speaking

Exclusion Criteria:

• COPD exacerbations requiring medical treatment last 4 weeks prior to inclusion led to deferment of inclusion

• Not safe to exercise (e.g unstable angina)

• mental illness and drug abuse that makes group treatment not suitable

Related Conditions & MeSH terms

• COPD
• Lung Diseases, Obstructive
• Pulmonary Disease, Chronic Obstructive

Intervention

Other:
• Pulmonary rehabilitation
Pre-post test design

Locations

Country	Name	City	State
Norway	Bente Frisk	Sandsli

Sponsors (3)

Lead Sponsor	Collaborator
Haukeland University Hospital	Norwegian Fund for Postgraduate Training in Physiotherapy, Western Norway University of Applied Sciences

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	6-minute walk test	Change from baseline to 6 weeks in 6 minute walk distance in meter is primary outcome	up to 6 weeks
Secondary	Incremental Shuttle walk test	Change from baseline to 6 weeks in walk distance in meter is the outcome	up to 6 weeks
Secondary	Endurance shuttle walk test	Change from baseline to 6 weeks in time in second is the outcome	up to 6 weeks
Secondary	30 second sit to stand test	Change from baseline to in number of repetition is the outcome	up to 6 weeks
Secondary	Stair test	Change from baseline to 6 weeks in time of the test is the outcome: 18 steps are walked up and down three times as fast as possible. Time in sec. is measured.	Up to 6 weeks